SHR-9803
- Generic Name
- SHR-9803
A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT06906731
- Locations
- 🇨🇳
Harbin Medical University cancer hospital, Harbin, Heilongjiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath